Implementation of EO on Access to Affordable, Life-Saving Medications
HHS has released a proposed rule to implement Executive Order 13937, which requires select entities that receive federal funding provide access to insulin and injectable epinephrine to low-income patients for the price at which the health center purchased them through the 340B Drug Pricing Program. Comments are due on October 28, 2020.

Removing Financial Disincentives to Living Organ Donation
HRSA has released a final rule that amends organ transplant regulations to remove financial barriers and expand the scope of reimbursable expenses incurred by living organ donors. The final rule is effective on October 22, 2020.

Reclassification of Transplant Patient Management Devices
The FDA has released a proposed rule that makes classification changes to devices used in the management of transplant patients’ care. Comments are due on November 17, 2020.

Open document to read more; page 8.